Luba Greenwood

Luba Greenwood is the Managing Partner of the Dana-Farber Cancer Institute Venture Fund, Binney Street Capital; CEO of Kojin Therapeutics; and co-founder and Managing Partner of Cathay Health. She is also a professor at Harvard University in the School of Engineering and Applied Sciences. Luba held leadership roles at Google Life Sciences and established and led the East Coast Innovation Hub as Vice President of Global Business Development and Mergers and Acquisitions at Roche. Luba has led $5B+ in deals and investments across multiple therapeutic areas and life sciences and tech sectors globally. She is a Thought Leader for the New England Journal of Medicine (NEJM) Catalyst. Luba started her career at Wilmer Cutler Pickering Hale and Dorris, and has experience as a litigator and regulatory, policy, and IP expert. She is a recipient of several awards and honors for her work in the community, including the Science Club for Girls Catalyst Award for her commitment to advocating for women in science and technology.